Literature DB >> 27625121

The optimal time between clinical brain death diagnosis and confirmation using CT angiography: a retrospective study.

Lionel Kerhuel1, Mohamed Srairi, Gilles Georget, Fabrice Bonneville, Ségolène Mrozek, Nicolas Mayeur, Laurent Lonjaret, Sandrine Sacrista, Nathalie Hermant, Fouad Marhar, François Gaussiat, Timothée Abaziou, Diane Osinski, Benjamin LE Gaillard, Rémi Menut, Claire Larcher, Olivier Fourcade, Thomas Geeraerts.   

Abstract

BACKGROUND: In several countries, a computed tomography angiography (CTA) is used to confirm brain death (BD). A six‑hour interval is recommended between clinical diagnosis and CTA acquisition despite the lack of strong evidence to support this interval. The aim of this study was to determine the optimal timing for CTA in the confirmation of BD.
METHODS: This retrospective observational study enrolled all adult patients admitted between January 2009 and December 2013 to the intensive care units of a French university hospital with clinically diagnosed BD and at least one CTA performed as a confirmatory test. The CTAs were identified as conclusive (e.g. yielding confirmation of BD) or inconclusive (e.g. showing persistent brain circulation).
RESULTS: One hundred and four patients (sex ratio M/F 1.8; age 55 years [41‑64]) underwent 117 CTAs. CTAs confirmed cerebral circulatory arrest in 94 cases yielding a sensitivity of 80%. Inconclusive CTAs were performed earlier than conclusive ones (2 hours [1‑3] vs. 4 hours [2‑9], P=0.03) and were associated with decompressive craniectomy (5 cases [23%] vs. 6 cases [7%], P=0.05) and the failure to complete full neurological examination (5 cases [23%] vs. 4 cases [5%], P=0.02). Six hours after BD clinical diagnosis, the proportion of conclusive CTA was only 51%, with progressive increase overtime with more than 80% of conclusive CTA after 12 hours.
CONCLUSIONS: A 12‑hour interval might be appropriate in order to limit the risk of inconclusive CTAs.

Entities:  

Mesh:

Year:  2016        PMID: 27625121

Source DB:  PubMed          Journal:  Minerva Anestesiol        ISSN: 0375-9393            Impact factor:   3.051


  2 in total

Review 1.  [Diagnosis of irreversible loss of brain function ("brain death")-what is new?]

Authors:  Uwe Walter; Stephan A Brandt
Journal:  Nervenarzt       Date:  2019-10       Impact factor: 1.214

2.  Implementing of Active Brain-Dead Donor Identification Strategy in a Single Donor Center: One Year Experience.

Authors:  Akvilina Trilikauskienė; Irena Maraulaitė; Diana Damanskytė; Dovilė Lukminaitė; Neringa Balčiūnienė; Tomas Tamošuitis
Journal:  Medicina (Kaunas)       Date:  2020-07-22       Impact factor: 2.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.